Characterization of the Binding Site for a Novel Class of Noncompetitive α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptor Antagonists

Arai, 1996, Effects of a memory-enhancing drug on DL-alpha-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic acid receptor currents and synaptic transmission in hippocampus., J Pharmacol Exp Ther, 278, 627

10.1016/0006-8993(94)90669-6

10.1016/0959-4388(94)90101-5

Buchan, 1993, AMPA antagonists: Do they hold more promise for clinical stroke trials than NMDA antagonists?, Stroke, 24, I-148

Buchan, 1991, Delayed AMPA receptor blockade reduces cerebral infarction induced by focal ischemia., Neuroreport, 2, 473, 10.1097/00001756-199108000-00016

10.1016/S0960-894X(01)81001-5

Chenard, 1999, Antagonists selective for NMDA receptors containing the NR2B subunit., Curr Pharmaceutical Design, 5, 381, 10.2174/138161280504230110102541

10.1016/S0960-894X(00)00216-X

Dingledine, 1999, The glutamate receptor ion channels., Pharmacol Rev, 51, 7

10.1016/0896-6273(93)90241-I

10.1016/0006-8993(92)90924-X

Hack, 1995, Properties of AMPA receptor expressed in rat cerebellar granule cell cultures: Ca2+ influx studies., J Neurochem, 65, 1077, 10.1046/j.1471-4159.1995.65031077.x

10.1016/0028-3908(94)00157-N

10.1111/j.1471-4159.1988.tb01060.x

10.1111/j.1471-4159.1982.tb10868.x

10.1073/pnas.90.2.605

10.1016/S0006-8993(97)01315-2

10.1002/ddr.430070307

Konkoy CS Ilyin VI Xia HJ Whittemore ER (1998) Substituted 2,3-benzodiazepinones as inhibitors and potentiators of native and cloned AMPA receptors (Abstract). Society for Neuroscience 28th Annual Meeting 24:99.

Lazzaro J. T. Ganong A. (1998) H CP-465,022 is a potent and selective noncompetitive AMPA receptor antagonist (Abstract). Society for Neuroscience 28th Annual Meeting 24:99.

10.1006/exnr.1997.6447

10.1016/0753-3322(94)90176-7

Menniti FS Collins M Ducat MF Kelly KA Pagnozzi MJ Richter KEG (1998) CP-465,022, a novel noncompetitive AMPA receptor antagonist: In vitro pharmacology (Abstract). Society for Neuroscience 28th Annual Meeting 24:99.

10.1016/0006-8993(94)90630-0

Newell LM, Sekhar V, De Vries KM, Staigers TL and Finneman JI (2000) Determination of the activation parameters for atropisomerization of (S)-3-(2-chlorophenyl)-2-[2-(6-diethylamonopyridin-2-yl)-vinyl]-6-fluoro-3H-quinazolin-4-one.Org Proc Res Dev, in press.

10.1021/jm00030a006

10.1016/S0166-2236(97)01184-3

10.1016/0006-8993(91)90653-D

10.1016/0896-6273(95)90227-9

Partin, 1996, Negative allosteric modulation of wild-type and mutant AMPA receptors by GYKI-53,655., Mol Pharmacol, 49, 142

10.1016/0896-6273(93)90220-L

10.1016/0896-6273(95)90253-8

10.1016/0165-6147(93)90005-5

Seymour PA Critchett D Guanowsky V Wilkinson LO (1998) CP-465,022, a novel noncompetitive AMPA receptor antagonist: In vivo pharmacology (Abstract). Society for Neuroscience 28th Annual Meeting 24:99.

10.1126/science.2154034

10.1016/0014-2999(93)90470-3

Shimizu-Sasamata, 1996, YM90K: Pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate kainate receptor antagonist., J Pharmacol Exp Ther, 276, 84

10.1126/science.1699275

Standley, 1998, High- and low-affinity alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) binding sites represent immature and mature forms of AMPA receptors and are composed of differentially glycosylated subunits., J Neurochem, 70, 2434, 10.1046/j.1471-4159.1998.70062434.x

10.1073/pnas.91.2.777

Tarnawa I Engberg I Flatman JA (1990) GYKI 52466, an inhibitor of spinal reflexes is a potent quisqualate antagonist. in Aminoacids: Biology, Chemistry, and Medicine, eds Lubec G Rosenthal GA (Escom, Leiden), pp 538–546.

Tarnawa, 1992, Inhibition of hippocampal field potentials by GYKI-52466 in vitro and in vivo., Acta Physiologica Hungarica, 79, 163

10.1016/0304-3940(96)12601-X

10.1016/0304-3940(96)12995-5

Welch WM Huang J-H Ewing FE Menniti FS Pagnozzi MJ Banker MJ Devries KM McCarthy KE (1998) Discovery of a potent and selective series of noncompetitive quinoxalinone AMPA antagonist and the preparation of an AMPA site radioligand (Abstract). Society for Neuroscience 28th Annual Meeting 24:99.

Wilding, 1995, Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines., Mol Pharmacol, 47, 582

Wilding, 1996, Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors., Mol Pharmacol, 49, 540

Xia H Field G Lan NC Wang Y Cai SX (1997) Substituted 2,3-benzodiazepin 4-ones and the use thereof. World patent no. 97/34878.

Yamada, 1993, Benzothiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic transmission., J Neurosci, 13, 3904, 10.1523/JNEUROSCI.13-09-03904.1993

10.1016/0920-1211(93)90054-B

Zorumski, 1993, A benzodiazepine recognition site associated with the non-NMDA glutamate receptor., Neuron, 10, 16, 10.1016/0896-6273(93)90242-J